Trilaciclib Injection

DRUG2 trials

Sponsors

Sun Yat-sen University, Taixing People's Hospital

Conditions

Breast CancerCervical CancerEndometrial CancerHead And Neck Squamous Cell CarcinomasNSCLCNon-Small Cell Lung Cancer

Phase 2

Myeloprotection With Trilaciclib in Pan-cancer Population

Not yet recruitingNCT06297811

Sun Yat-sen UniversityBreast Cancer, Cervical Cancer, Endometrial Cancer +2

Start: 2024-03-01End: 2027-12-31Target: 132Updated: 2024-03-07

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC

RecruitingNCT06328049

Taixing People's HospitalNSCLC

Start: 2023-08-10End: 2025-08-10Target: 30Updated: 2024-03-25